BACKGROUND: Retinol-binding protein (RBP) 4, a human adipokine that specifically binds to retinol, has been reported to provide a link between obesity and insulin resistance. Plasma RBP4 concentration may be under the influence of age and obesity, but only a few studies has investigated this link in elderly individuals. Consequently, we tested the correlation between RBP4 concentrations and type 2 diabetes/metabolic syndrome (MetS) components in a large population based cohort study (VITA) of elderly [1, 2]. Using a single birth cohort, this investigation could exclude the influence of age. METHODS: We evaluated the correlation of RBP4 with type 2 diabetes and MetS components including Body Mass Index (BMI), blood pressure, lipid parameters, fasting glucose insulin, homeostasis model assessment insulin resistance (HOMA-IR), and smoking in exclusively 75-76 year old participants (N = 232). RESULTS: In the present study, RBP4 concentrations were associated with type 2 diabetes and metabolic syndrome (MetS) components. Of all the individual components of metabolic syndrome that were associated with RBP4 concentrations, the correlations of RBP4 with serum triglycerides and a negative correlation with HDL were the strongest ones observed in our study cohort (p<0.0001). CONCLUSIONS: RBP4 plays a role in biological mechanisms that are responsible for insulin resistance and development of type 2 diabetes.
BACKGROUND: Retinol-binding protein (RBP) 4, a human adipokine that specifically binds to retinol, has been reported to provide a link between obesity and insulin resistance. Plasma RBP4 concentration may be under the influence of age and obesity, but only a few studies has investigated this link in elderly individuals. Consequently, we tested the correlation between RBP4 concentrations and type 2 diabetes/metabolic syndrome (MetS) components in a large population based cohort study (VITA) of elderly [1, 2]. Using a single birth cohort, this investigation could exclude the influence of age. METHODS: We evaluated the correlation of RBP4 with type 2 diabetes and MetS components including Body Mass Index (BMI), blood pressure, lipid parameters, fasting glucose insulin, homeostasis model assessment insulin resistance (HOMA-IR), and smoking in exclusively 75-76 year old participants (N = 232). RESULTS: In the present study, RBP4 concentrations were associated with type 2 diabetes and metabolic syndrome (MetS) components. Of all the individual components of metabolic syndrome that were associated with RBP4 concentrations, the correlations of RBP4 with serum triglycerides and a negative correlation with HDL were the strongest ones observed in our study cohort (p<0.0001). CONCLUSIONS: RBP4 plays a role in biological mechanisms that are responsible for insulin resistance and development of type 2 diabetes.
Authors: Michael B Zimmermann; Christophe Zeder; Nourredine Chaouki; Toni Torresani; Amina Saad; Richard F Hurrell Journal: Eur J Endocrinol Date: 2002-12 Impact factor: 6.664
Authors: Shai Gavi; Louise M Stuart; Patricia Kelly; Mark M Melendez; Dennis C Mynarcik; Marie C Gelato; Margaret A McNurlan Journal: J Clin Endocrinol Metab Date: 2007-02-13 Impact factor: 5.958
Authors: Qin Yang; Timothy E Graham; Nimesh Mody; Frederic Preitner; Odile D Peroni; Janice M Zabolotny; Ko Kotani; Loredana Quadro; Barbara B Kahn Journal: Nature Date: 2005-07-21 Impact factor: 49.962
Authors: Shai Gavi; Saima Qurashi; Louise M Stuart; Raymond Lau; Mark M Melendez; Dennis C Mynarcik; Margaret A McNurlan; Marie C Gelato Journal: Obesity (Silver Spring) Date: 2008-01-31 Impact factor: 5.002
Authors: Aiwei Yao-Borengasser; Vijayalakshmi Varma; Angela M Bodles; Neda Rasouli; Bounleut Phanavanh; Mi-Jeong Lee; Tasha Starks; Leslie M Kern; Horace J Spencer; Amir Adel Rashidi; Robert E McGehee; Susan K Fried; Philip A Kern Journal: J Clin Endocrinol Metab Date: 2007-06-26 Impact factor: 5.958
Authors: Mei Du; Laura Otalora; Ashley A Martin; Gennadiy Moiseyev; Phillip Vanlandingham; Qilong Wang; Rafal Farjo; Alexander Yeganeh; Alexander Quiambao; Krysten M Farjo Journal: Mol Cell Biol Date: 2015-06-08 Impact factor: 4.272
Authors: Mei Du; Eric Phelps; Michael J Balangue; Aaron Dockins; Gennadiy Moiseyev; Younghwa Shin; Shelley Kane; Laura Otalora; Jian-Xing Ma; Rafal Farjo; Krysten M Farjo Journal: Invest Ophthalmol Vis Sci Date: 2017-08-01 Impact factor: 4.799
Authors: M Majerczyk; P Kocełak; P Choręza; H Arabzada; A J Owczarek; M Bożentowicz-Wikarek; A Brzozowska; A Szybalska; M Puzianowska-Kuźnicka; T Grodzicki; A Więcek; M Olszanecka-Glinianowicz; J Chudek Journal: J Endocrinol Invest Date: 2018-03-09 Impact factor: 4.256